Robert L. Keith, M.D.
Dr. Keith is Associate Professor of Medicine, University of Colorado at Denver – School of Medicine, and Associate Chief of Staff – Research, Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, VA Eastern Colorado Healthcare System.
Within the past 12 months, Dr. Keith reports he has been on the Speakers Bureau for Pfizer and Boeringer-Ingelheim.
Albert Einstein College of Medicine, CCME staff, and interMDnet staff have nothing to disclose.
Estimated course time: 1 hour(s).
Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Upon completion of this Cyberounds®, you should be able to:
Describe the principles of chemoprevention, including primary, secondary, and tertiary.
Provide the definition of a biomarker
Describe the risk factors for lung cancer
List interventions agents that have proven to be effective in lung cancer chemoprevention
Discuss the principles of personalized chemoprevention and how these concepts will be applied in lung cancer chemoprevention trials.
